PRELIMINARY RESULTS OF DARATUMUMAB, CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIED TREATMENT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TRANSPLANT ELIGIBLE (TE) PATIENTS

oleh: E.Q. CrusoƩ, M.A. Salvino, S.Q. Silva, H.H.M. Santos, A.S. Santos, A.M. Almeida, L.O. Vieira, C.A. Fonseca, L.F. Lucas, J.S. Leal, M.M. Santos, J.A. Santos, E. Adorno, V.T.M. Hungria, M.G.B. Arruda

Format: Article
Diterbitkan: Elsevier 2020-11-01

Deskripsi

No description available for this item.